Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Empowering India’s Digital Economy: HaodaPay’s Contribution to a Cashless Nation Business
  • Utkarsh Saxena is all geared up for Tum Bhi Pachtaoge featuring Mohd Sharia Entertainment
  • Aaomi by Shiloh Launches Mumbai’s First-Ever Moon & Galaxy-Themed Restaurant at Sky City Mall, Borivali Entertainment
  • Creative International Styling School (CISS), Mumbai Marked Its Grand Launch with Industry Luminaries and K-Pop Star Aoora Lifestyle
  • Singer Diamond: A Rising Star in the Music Industry Entertainment
  • Aayush Wellness Limited Stock Price Up Over 50% In A Month; Locked In Back To Back Buyer Circuits Business
  • Every Bed. Every Vital. Every Second. ASTA HealthTech Is Building the Intelligence Layer for Tomorrow’s Hospitals. Lifestyle
  • Children Cannot Live With Covid-19 and Other Mysterious Diseases Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • JIPSI and Dr. Gaurav Kant Sharma: Revolutionizing Sports Injury Treatment for Athletes Health
  • Best Health Experts in India Advice on Gynecologic & Blood Cancers Health
  • Flawora-Transforming Skincare with Potent Science Health
  • Medical Science Revolutionized: Cell Regeneration Offers Hope for Dysfunctional Organs Health
  • Global Healthcare Academy Hosts Successful – Best of ASCO, Conference in Bengaluru Health
  • Cranberries: A Nutritional Powerhouse for Gut and Overall Health Health

Recent Posts

  • Magellanic Cloud’s Wholly Owned Subsidiary Provigil Surveillance Limited Emerges as L1 Bidder in Bank of Maharashtra’s E-Surveillance Tender with a Bid Value of approx. Rs 228 Crore
  • Cold Konnect: A Three-Generation Bet on India’s Farmers
  • Raymond Plans Name Change to Raymond Aerospace, Defence & Engineering Limited; Board Approves Proposal
  • Apollo Micro Systems Q2 Profit Jumps 54%, Revenue Rises 72% to Rs 388 Crore
  • Eight Parul University Researchers Recognised Among the World’s Top 2% Scientists in Stanford-Elsevier Rankings 2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Akila Agrawal’s debut fiction, ‘Marriages Not Made in Heaven’, is a humorous but insightful exploration of modern-day marriages Business
  • Steel Exchange India Limited Clocks Approximately ~Rs 340 Crore Revenue in Q2 FY27, up ~45% YoY and ~25% QoQ, Driven by Record Re-bar Production Business
  • Sampark 2025, IEEE Gujarat Section’s 20th Edition Ends on a High Note Lifestyle
  • Franklin Industries Ltd’s Rs. 38.83 crore Rights opened from May 24 Business
  • Komal Thacker Shines Bright at Cannes Film Festival for the Second Year in a Row Entertainment
  • Go Big or Go Home: Cellecor Gadgets Limited all set to roll out 75, 86, and 98 inch Premium Smart TVs! Business
  • The husband-and-wife duo built a complete health solution to fight micronutrient deficiency in India Health
  • Pictor Telematics: Revolutionizing the GPS Tracking Industry in India and Beyond Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme